Pentazocine Hcl And Naloxone Hcl
Product Images NDC 16590-556

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentazocine Hcl And Naloxone Hcl (NDC 16590-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Naloxone Structure Image (Naloxone Structure)

FDA Label Image

Pentazocine Structure Image (Pentazocine Structure)

FDA Label Image

Pentazocine-naloxone 50mg 0-5mg Label Image (Pentazocine Naloxone 50mg 0 5mg Label)

Pentazocine-naloxone 50mg 0-5mg Label Image (Pentazocine Naloxone 50mg 0 5mg Label)
This is a label of a medicine package containing pentazocine and naloxone. Each tablet contains 50mg of Pentazocine Hel. USP and 0.5mg of Naloxane Hel., USP. The medicine is manufactured by Walsan Pharma and the package was distributed from Corona, CA. The medicine may cause drowsiness or dizziness and should not be used with alcohol or while operating dangerous machinery. The expiry date of the medicine is October 11, 2020.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.